Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

Substance P may contribute to hair loss by increasing oxidative stress and mitochondrial activity in hair follicles.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Different types of hair loss have unique cellular changes, suggesting new treatment targets.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Smart biomaterials and dressings show promise in treating chronic skin diseases by improving drug delivery and minimizing side effects.

Certain microRNAs might help identify and understand Frontal Fibrosing Alopecia.

The conclusion is that fat tissue in the skin is a new finding in Frontal fibrosing alopecia and may contribute to hair follicle and muscle degeneration.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Impaired autophagy may contribute to alopecia areata.

Nanocrystals improve alopecia areata treatment by better targeting hair follicles.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Being allergic to linalool, a common fragrance ingredient, might contribute to developing frontal fibrosing alopecia.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Ritlecitinib is safe and may effectively treat alopecia areata.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

CLEC4D gene variants may increase the risk of alopecia areata in Jordanians.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Laser treatment, especially when combined with other therapies, is effective for hair regrowth in alopecia areata.